Altered vascular function, arterial stiffness, and antioxidant gene responses in pediatric thalassemia patients.

Pediatric Cardiology
Pantipa DetchapornVeerapol Kukongviriyapan

Abstract

Patients with thalassemia major are susceptible to cardiovascular complications by mechanisms not fully understood. Although overt cardiovascular complications usually occur after puberty, their underlying pathogenesis may begin much earlier. This study investigated whether there were early changes in vascular endothelial function and arterial stiffness in young patients with beta-thalassemia and hemoglobin E, and whether these changes were associated with oxidative stress and expression of antioxidant genes. The study recruited 30 pediatric patients and 30 age-matched control subjects. Compared with the control subjects, the patients had increased levels of oxidant biomarkers including malondialdehyde, protein carbonyl, and non-transferrin-bound iron and a decreased glutathione redox ratio. There were clear signs of vascular endothelial dysfunction and increased arterial stiffness, as shown by marked suppression of forearm blood flow after reactive hyperemia and increased pulse-wave velocity in the trunk and legs. The changes in FBF were associated with oxidative stress markers and free iron. An adaptive antioxidant gene response was activated in blood mononuclear cells, as shown by upregulation of GCLC and Bach-1 mRNA but dow...Continue Reading

References

Jul 8, 1999·The New England Journal of Medicine·N F Olivieri
Dec 29, 2000·Journal of Pediatric Hematology/oncology·D J Weatherall
Mar 16, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·D Chakraborty, M Bhattacharyya
Sep 7, 2002·Physiological Measurement·Stavros LoukogeorgakisStephen E Greenwald
Apr 5, 2003·Stroke; a Journal of Cerebral Circulation·Stéphane LaurentPierre Boutouyrie
Feb 28, 2004·Blood·Melody J CunninghamUNKNOWN Thalassemia Clinical Research Network
Jun 8, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Dean P JonesWard G Kirlin
Jul 17, 2004·Free Radical Biology & Medicine·Truyen NguyenCecil B Pickett
Oct 2, 2004·European Journal of Haematology·Athanasios AessoposMarkisia Karagiorga
Sep 17, 2005·The American Journal of Medicine·George HahalisNicholas C Zoumbos
Oct 7, 2005·International Journal of Cardiology·Constadina AggeliChristodoulos Stefanadis
Nov 4, 2005·European Heart Journal·Katerina K NakaAndrew H Henderson
Feb 8, 2006·Circulation·Francesco U S Mattace-RasoJacqueline C M Witteman
Apr 8, 2006·Physiological Reviews·Stefan W RyterAugustine M K Choi
May 23, 2006·Atherosclerosis·Athanasios AessoposMarkisia Karagiorga
Sep 28, 2006·Journal of Biochemistry and Molecular Biology·Ebenezer Olatunde Farombi, Young Joon Surh
Nov 23, 2006·European Journal of Clinical Pharmacology·Nuntiya SomparnVeerapol Kukongviriyapan
Sep 25, 2007·Pediatric Cardiology·Veerapol KukongviriyapanArunee Jetsrisuparb
Sep 4, 2009·Archives of Pharmacal Research·Young-Joon SurhYoung-Nam Cha

❮ Previous
Next ❯

Citations

Jun 22, 2013·Cardiovascular Diabetology·Suphawadee PhababphaStephen E Greenwald
Mar 24, 2016·Annals of the New York Academy of Sciences·Dustin R Fraidenburg, Roberto F Machado
Jul 1, 2017·Metallomics : Integrated Biometal Science·G E GencS Gumuslu
May 6, 2017·International Journal of Hematology·Sudarat SatitthummanidSuphot Srimahachota
Nov 11, 2019·British Journal of Pharmacology·Helbert Gabriel FidelisLeonardo Dos Santos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.